Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. Thomas Fekete Offers Insight to WHYY about Merck’s New Drug Molnupiravir, Which Could Be the First Pill to Treat COVID-19

View All News

Thomas Fekete, MD, MACP, Thomas Durant Chair and Professor of Medicine and Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University, offered insight to WHYY about Merck’s new drug molnupiravir, which could be the first pill to treat COVID-19. Merck has asked the U.S. Food and Drug Administration to authorize the treatment.